var data={"title":"Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributors\" class=\"contributor contributor_credentials\">Charles J Lockwood, MD, MHCM</a></dd><dd><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributors\" class=\"contributor contributor_credentials\">Karen Russo-Stieglitz, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributors\" class=\"contributor contributor_credentials\">Deborah Levine, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributors\" class=\"contributor contributor_credentials\">Vincenzo Berghella, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributors\" class=\"contributor contributor_credentials\">Vanessa A Barss, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 04, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placenta previa refers to the presence of placental tissue that extends over the internal cervical os. Sequelae include the potential for severe bleeding and preterm birth, as well as the need for cesarean delivery.</p><p>Placenta previa should be suspected in any pregnant woman beyond 20 weeks of gestation who presents with vaginal bleeding. For women who have not had a second-trimester ultrasound examination, bleeding after 20 weeks of gestation should prompt sonographic determination of placental location <strong>before</strong> digital vaginal examination is performed because palpation of the placenta can cause severe hemorrhage.</p><p>This topic will discuss the epidemiology, clinical features, diagnosis, morbidity, and mortality of placenta previa. The natural history of placenta, risk of bleeding, and management are reviewed separately. (See <a href=\"topic.htm?path=placenta-previa-management\" class=\"medical medical_review\">&quot;Placenta previa: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H1154183122\"><span class=\"h2\">Prevalence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In systematic reviews, the pooled prevalence of placenta previa is about 4 per 1000 births, but varies worldwide [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The prevalence is several-fold higher around 20 weeks of gestation (as high as 2 percent), but most previas identified early in pregnancy resolve before delivery. (See <a href=\"#H1226729935\" class=\"local\">'Natural history'</a> below.)</p><p class=\"headingAnchor\" id=\"H635460758\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Major risk factors for placenta previa include [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/3-15\" class=\"abstract_t\">3-15</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Previous placenta previa</strong> &ndash; Placenta previa recurs in 4 to 8 percent of subsequent pregnancies [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/16\" class=\"abstract_t\">16</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Previous cesarean delivery</strong> &ndash; In two systematic reviews, previous cesarean delivery was found to increase the risk for placenta previa by 47 percent [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/17\" class=\"abstract_t\">17</a>] and 60 percent [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/3\" class=\"abstract_t\">3</a>]. The risk increases with an increasing number of cesarean deliveries [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/18-20\" class=\"abstract_t\">18-20</a>]. Prelabor cesarean delivery may increase previa risk in a subsequent delivery more than previous intrapartum cesarean or vaginal delivery [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Multiple gestation</strong> &ndash; The prevalence of placenta previa was 40 percent higher among twin births than among singleton births (3.9 and 2.8 per 1000 births, respectively) in one study [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/5\" class=\"abstract_t\">5</a>]. In another study, dichorionic twin pregnancies were more likely to have a placenta previa than monochorionic twin pregnancies (odds ratio [OR] 3.3) or singleton pregnancies (OR 1.5) [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/21\" class=\"abstract_t\">21</a>].</p><p/><p>Other risk factors, some of which are interdependent, include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increasing parity</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increasing maternal age</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infertility treatment</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous abortion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous uterine surgical procedure</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maternal smoking</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maternal cocaine use</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Male fetus</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Non-white race</p><p/><p class=\"headingAnchor\" id=\"H1783986\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of placenta previa is unknown. One hypothesis is that the presence of areas of suboptimally vascularized decidua in the upper uterine cavity due to previous surgery or multiple pregnancies promotes implantation of trophoblast in, or unidirectional growth of, trophoblast toward the lower uterine cavity [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/1,3,22\" class=\"abstract_t\">1,3,22</a>]. Another hypothesis is that a particularly large placental surface area, as in multiple gestation, increases the probability that the placenta will encroach <span class=\"nowrap\">upon/cover</span> the cervical os. </p><p class=\"headingAnchor\" id=\"H1829329\"><span class=\"h1\">PATHOPHYSIOLOGY OF BLEEDING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placental bleeding is the major adverse sequelae of placenta previa. It is thought to occur when uterine contractions or gradual changes in the cervix and lower uterine segment apply shearing forces to the inelastic placental attachment site, resulting in partial detachment. Vaginal examination or coitus can also disrupt this site and cause bleeding. Bleeding is primarily maternal blood from the intervillous space, but fetal bleeding can occur if fetal vessels in the terminal villi are disrupted.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL PRESENTATION AND COURSE</span></p><p class=\"headingAnchor\" id=\"H1783334\"><span class=\"h2\">Asymptomatic finding on midtrimester ultrasound examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common presentation of placenta previa is as a finding on routine ultrasound examination at about 16 to 20 weeks of gestation for assessment of gestational age, fetal anatomic survey, or prenatal diagnosis. One to 6 percent of pregnant women are found to have sonographic evidence of a placenta previa on these examinations. (See <a href=\"#H1398236\" class=\"local\">'Ultrasonography'</a> below.)</p><p class=\"headingAnchor\" id=\"H1226729935\"><span class=\"h3\">Natural history</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 90 percent of placenta previas identified on ultrasound examination before 20 weeks of gestation resolve before delivery [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/23\" class=\"abstract_t\">23</a>]. Two theories have been proposed to account for this phenomenon:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The lower uterine segment lengthens from 0.5 cm at 20 weeks of gestation to more than 5 cm at term [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/16\" class=\"abstract_t\">16</a>]. This development of the lower uterine segment relocates the stationary lower edge of the placenta away from the internal os.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Progressive unidirectional growth of trophoblastic tissue toward the fundus results in upward migration of the placenta away from the cervix. This phenomenon has been termed &quot;trophotropism.&quot;</p><p/><p>In either case, the placental edge overlying the cervix atrophies.</p><p class=\"headingAnchor\" id=\"H1398634279\"><span class=\"h3\">Predicting presence at delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Findings that suggest that a placenta previa will persist until delivery include lack of resolution by the third trimester and extension over the os by more than 25 mm.</p><p>In a retrospective cohort study of 714 women with placenta previa, singleton gestation, and a liveborn infant &ge;25 weeks of gestation, when the most recent ultrasound showed placenta previa at [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/24\" class=\"abstract_t\">24</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>15 to 19 weeks &ndash; 20 percent were present at delivery if no prior cesarean delivery, and 41 percent if a prior cesarean delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>20 to 23 weeks &ndash; 45 percent were present at delivery if no prior cesarean delivery, and 73 percent if a prior cesarean delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>24 to 27 weeks &ndash; 56 percent were present at delivery if no prior cesarean delivery, and 84 percent if a prior cesarean delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>28 to 31 weeks &ndash; 88 to 89 percent were present at delivery whether or not there was a prior cesarean delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>32 to 35 weeks &ndash; 89 to 90 percent were present at delivery whether or not there was a prior cesarean delivery</p><p/><p>The more the placenta extends over the internal os, the more likely it is to persist until delivery. Although available data are insufficient to make precise predictions, pooled data suggest that when the placenta extends at least 14 to 15 mm but &lt;25 mm over the cervical os at 18 to 23 weeks of gestation, then the probability of placenta previa at delivery is about 20 percent; extension &ge;25 mm is associated with a 40 to 100 percent probability of placenta previa at delivery [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/25-29\" class=\"abstract_t\">25-29</a>].</p><p>Low-lying placentas and placentas formerly called partial previa are most likely to resolve (eg, only 6 to 7 percent of those diagnosed at 15 to 19 weeks and 39 to 63 percent of those diagnosed at 32 to 35 weeks were present at delivery). Anterior placenta previas are more likely to resolve than posterior placenta previa [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Recommendations for follow-up sonography to determine resolution are discussed separately. (See <a href=\"topic.htm?path=placenta-previa-management#H4763313\" class=\"medical medical_review\">&quot;Placenta previa: Management&quot;, section on 'Monitoring placental position'</a>.)</p><p class=\"headingAnchor\" id=\"H524431\"><span class=\"h2\">Bleeding</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the second half of pregnancy, the most common symptom of placenta previa is relatively painless vaginal bleeding, which occurs in up to 90 percent of persistent cases [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/31\" class=\"abstract_t\">31</a>]. Ten to 20 percent of women present with uterine contractions, pain, and bleeding, similar to the presentation of abruptio placenta [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/32,33\" class=\"abstract_t\">32,33</a>]. (See <a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Placental abruption: Clinical features and diagnosis&quot;</a>.)</p><p>In approximately one-third of pregnancies with persistent previa, the initial bleeding episode occurs prior to 30 weeks of gestation; this group is more likely to require blood transfusions and is at greater risk of preterm delivery and perinatal mortality than women whose bleeding begins later in gestation [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/32-35\" class=\"abstract_t\">32-35</a>]. An additional one-third of patients becomes symptomatic between 30 and 36 weeks, while most of the remaining patients have their first bleed after 36 weeks [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/32,33\" class=\"abstract_t\">32,33</a>]. About 10 percent of women reach term without bleeding. The number of antepartum bleeding episodes and need for blood transfusion have been identified as independent predictors for emergency cesarean delivery [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/36\" class=\"abstract_t\">36</a>].</p><p>Antepartum bleeding from any cause is a risk factor for preterm labor and preterm premature rupture of membranes. (See <a href=\"topic.htm?path=pathogenesis-of-spontaneous-preterm-birth#H9\" class=\"medical medical_review\">&quot;Pathogenesis of spontaneous preterm birth&quot;, section on 'Decidual hemorrhage'</a> and <a href=\"topic.htm?path=preterm-prelabor-rupture-of-membranes#H450395235\" class=\"medical medical_review\">&quot;Preterm prelabor rupture of membranes&quot;, section on 'Risk factors'</a>.)</p><p class=\"headingAnchor\" id=\"H1398189\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of placenta previa is based on sonography and requires the identification of echogenic homogeneous placental tissue over the internal cervical os.</p><p>Placenta previa should be suspected in any woman beyond 20 weeks of gestation who presents with vaginal bleeding. For women who have not had a second- or third-trimester ultrasound examination, antepartum bleeding should prompt sonographic determination of placental location before digital vaginal examination is performed because palpation of the placenta can cause severe hemorrhage.</p><p class=\"headingAnchor\" id=\"H71784423\"><span class=\"h2\">Diagnostic criteria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of placenta previa is based on identification of placental tissue extending over the internal cervical os on a second or third trimester imaging study (<a href=\"image.htm?imageKey=OBGYN%2F74665\" class=\"graphic graphic_diagnosticimage graphicRef74665 \">image 1</a>), preferably transvaginal ultrasound [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/37\" class=\"abstract_t\">37</a>]. The distance (millimeters) that the placenta extends over the internal cervical os should be described in the diagnostic report.</p><p>Of note, when the placental edge is &lt;2 cm from, but not over, the internal os, the placenta is labeled &quot;low-lying&quot; (<a href=\"image.htm?imageKey=OBGYN%2F55703\" class=\"graphic graphic_diagnosticimage graphicRef55703 \">image 2</a>). The distance (millimeters) between the internal cervical os and the inferior edge of the placenta should be described in the diagnostic report [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"#H1491902675\" class=\"local\">'Morbidity of low-lying placenta'</a> below.)</p><p>The historic terms &quot;marginal&quot; and &quot;partial&quot; for characterizing a placenta previa are no longer used, as they referred to information gathered on a digital vaginal examination, which should be avoided and is not needed given the superiority of ultrasound diagnosis.</p><p class=\"headingAnchor\" id=\"H1398236\"><span class=\"h2\">Ultrasonography</span></p><p class=\"headingAnchor\" id=\"H1398243\"><span class=\"h3\">Transabdominal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transabdominal sonographic assessment of placental location is one of the standard components of the basic obstetrical ultrasound examination, and thus can be considered a screening test for placenta previa.</p><p class=\"headingAnchor\" id=\"H4069193567\"><span class=\"h4\">Screening performance</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If the placenta-cervix distance is &le;2 cm on transabdominal ultrasound, we perform transvaginal sonography to better define placental position and make the diagnosis. The overall false positive rate of transabdominal ultrasound for diagnosis of placenta previa is up to 25 percent, and varies by study design [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/39,40\" class=\"abstract_t\">39,40</a>]. In a planned secondary analysis of a prospective cohort study of women with singleton gestations undergoing both transabdominal and transvaginal cervical length measurement during the second trimester anatomic survey, a transabdominal placenta-cervix distance threshold of 4.2 cm had sensitivity 93.3 percent, specificity 76.7 percent, negative predictive value 99.8 percent, and screen-positive rate 25.0 percent for detection of previa [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/41\" class=\"abstract_t\">41</a>]. A threshold of 2.8 cm yielded a sensitivity 86.7 percent, specificity 90.5 percent, negative predictive value 99.6 percent, and screen-positive rate of 11.4 percent. Thus, a threshold of 2.8 cm maximizes specificity while a threshold of 4.2 cm maximizes sensitivity.</p><p class=\"headingAnchor\" id=\"H4241803197\"><span class=\"h4\">Technique and pitfalls</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sagittal, parasagittal, and transverse sonographic views should be obtained with the patient's bladder partially full.</p><p>Specific points that should be appreciated when performing transabdominal sonographic examination for placenta previa include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An over-distended bladder can compress the anterior lower uterine segment against the posterior lower uterine segment to give the appearance of a previa (<a href=\"image.htm?imageKey=OBGYN%2F76545\" class=\"graphic graphic_diagnosticimage graphicRef76545 \">image 3</a>). The diagnosis of placenta previa should not be made without confirming placental position after the patient has emptied her bladder. Care should be taken to not make the diagnosis of placenta previa when the lower uterine segment is contracting, which commonly occurs after a woman empties her bladder, and obscures the relationship between the placental edge and the cervical os.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A previa can be missed near term if the fetal head is low in the pelvis since acoustic shadowing from or compression of placental tissue by the fetal skull may obscure the placental location. In these cases, the cervix may be better visualized by placing the patient in Trendelenburg position <span class=\"nowrap\">and/or</span> gently pushing the fetal head cephalad with an abdominal hand or the transducer.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The sonographic diagnosis of a central placenta previa is readily made since the placenta is centered over the cervix and placental tissue is imaged anterior and posterior to the cervix. Complete noncentral previas, particularly when lateral, are more difficult to confirm. Transverse views at and above the internal cervical os should facilitate an accurate diagnosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A posterior placenta previa may be more difficult to visualize than an anterior placenta previa, even on transvaginal ultrasound.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bleeding can result in formation of a hematoma under <span class=\"nowrap\">and/or</span> proximate to the placenta, which can obscure the relationship between the placental edge and the cervical os.</p><p/><p class=\"headingAnchor\" id=\"H1398250\"><span class=\"h3\">Transvaginal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transvaginal ultrasound (TVS) can be performed safely in patients with placenta previa since the optimal position of the vaginal probe for visualization of the internal os is 2 to 3 cm away from the cervix, and the angle between the cervix and vaginal probe is sufficient to prevent the probe from inadvertently slipping into the cervical canal [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/42\" class=\"abstract_t\">42</a>].</p><p class=\"headingAnchor\" id=\"H651487460\"><span class=\"h4\">Performance</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>TVS generally provides a clearer image of the relationship between the edge of the placenta and the internal cervical os than transabdominal ultrasound. Randomized trials and prospective comparative studies have established the superior performance of TVS over transabdominal sonography for diagnosis of placenta previa [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/43-45\" class=\"abstract_t\">43-45</a>]. In one study of 100 suspected cases, sensitivity, specificity, and positive and negative predictive values of TVS for diagnosis of placenta previa at cesarean were 87.5, 98.8, 93.3, 97.6 percent, respectively [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Use of color Doppler is employed in the cases of suspected morbidly adherent placentation (eg, accreta) or umbilical cord in the lower uterine segment, to rule out a vasa previa. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;</a> and <a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">&quot;Velamentous umbilical cord insertion and vasa previa&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2068534580\"><span class=\"h4\">Characteristics predictive of bleeding</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the magnitude of bleeding risk may differ according to the following characteristics, all patients with placentas over or in close proximity to the cervical os are at risk of significant antepartum, intrapartum, and postpartum bleeding.</p><p>Characteristics that appear to be predictive of antepartum bleeding include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extension over the internal os rather than lying proximate to it [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/47-50\" class=\"abstract_t\">47-50</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thick (&gt;1 cm) placental edge <span class=\"nowrap\">and/or</span> angle between the basal and chorionic plates greater than 45 degrees [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/51,52\" class=\"abstract_t\">51,52</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Echo-free space in the placental edge over the internal os [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/53\" class=\"abstract_t\">53</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cervical length &le;3 cm [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/52,54,55\" class=\"abstract_t\">52,54,55</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decrease in cervical length in the third trimester [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/56,57\" class=\"abstract_t\">56,57</a>].</p><p/><p class=\"headingAnchor\" id=\"H2798478593\"><span class=\"h3\">Other ultrasound techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Translabial (transperineal) ultrasound imaging is an alternative technique that provides excellent images of the cervix and placenta [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/58\" class=\"abstract_t\">58</a>]. The use of three-dimensional ultrasound may also improve accuracy [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/59\" class=\"abstract_t\">59</a>].</p><p class=\"headingAnchor\" id=\"H1398257\"><span class=\"h2\">Magnetic resonance imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Magnetic resonance imaging (MRI) is well-suited to the assessment of placental-cervical relationships because of the differing magnetic resonance characteristics of the two tissues. However, it is not used for diagnosis of placenta previa because of its high cost, limited availability, and the well-established safety and accuracy of transvaginal sonography [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/38\" class=\"abstract_t\">38</a>]. MRI is most useful for diagnosis of complicated placenta previa, such as previa-accreta and previa-percreta [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/60\" class=\"abstract_t\">60</a>]. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1398271\"><span class=\"h1\">ASSOCIATED FINDINGS</span></p><p class=\"headingAnchor\" id=\"H1398279\"><span class=\"h2\">Placenta previa-accreta</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When placenta previa is diagnosed, the possibility of placenta previa-accreta (or more) should be considered. In a prospective study including 723 women with placenta previa undergoing cesarean delivery, the frequency of placenta accreta increased with an increasing number of cesarean deliveries as follows [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/61\" class=\"abstract_t\">61</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>First cesarean birth, 3 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Second cesarean birth, 11 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Third cesarean births, 40 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fourth cesarean births, 61 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fifth or greater cesarean birth, 67 percent</p><p/><p>In another large series, composite maternal morbidity in women with placenta previa and zero, one, two, or three prior cesarean deliveries was 15, 23, 59, and 83 percent, respectively, and almost all of the excess composite maternal morbidity in women with a prior cesarean was related to complications associated with placenta accreta, such as peripartum hysterectomy [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/62\" class=\"abstract_t\">62</a>]. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1235055223\"><span class=\"h2\">Other associated findings</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Malpresentation</strong> &ndash; The large volume of placenta in the lower portion of the uterine cavity predisposes the fetus to assume a noncephalic lie [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/43,63-65\" class=\"abstract_t\">43,63-65</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Vasa previa and velamentous umbilical cord</strong> &ndash; Placenta previa is a risk factor for vasa previa and velamentous umbilical cord insertion. (See <a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">&quot;Velamentous umbilical cord insertion and vasa previa&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intrauterine growth restriction</strong> &ndash; An increased risk of intrauterine growth restriction has been reported by multiple [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/8,32,66-71\" class=\"abstract_t\">8,32,66-71</a>], but not all [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/34,35,66,72-74\" class=\"abstract_t\">34,35,66,72-74</a>], investigators, and remains controversial. If a reduction in fetal growth occurs, it is likely to be mild or due to confounding factors. For example, decreased placental perfusion can lead to both fetal growth restriction and a suboptimal site of placental implantation. (See <a href=\"topic.htm?path=fetal-growth-restriction-evaluation-and-management\" class=\"medical medical_review\">&quot;Fetal growth restriction: Evaluation and management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Congenital anomalies</strong> &ndash; Population-based cohort studies have reported a small increase in the overall rate of congenital anomalies in pregnancies complicated by placenta previa, but no single anomaly or syndrome was associated with the disorder [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/8,35,75,76\" class=\"abstract_t\">8,35,75,76</a>].</p><p/><p class=\"headingAnchor\" id=\"H1830439\"><span class=\"h1\">MORBIDITY AND MORTALITY</span></p><p class=\"headingAnchor\" id=\"H1830447\"><span class=\"h2\">Maternal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Maternal morbidity from placenta previa is primarily related to antepartum <span class=\"nowrap\">and/or</span> postpartum hemorrhage [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/77\" class=\"abstract_t\">77</a>]. In systematic reviews, 52 percent of women with placenta previa had antepartum bleeding (95% CI 42.7 to 60.6 percent) [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/31\" class=\"abstract_t\">31</a>] and 22 percent had postpartum hemorrhage (95% CI 15.8 to 28.7 percent) [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/78\" class=\"abstract_t\">78</a>]. Because of antepartum <span class=\"nowrap\">and/or</span> postpartum bleeding, women with placenta previa are more likely to receive blood transfusions (12 versus 0.8 percent in patients without previa in one study [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/65\" class=\"abstract_t\">65</a>], 22 versus 1.2 percent in another [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/8\" class=\"abstract_t\">8</a>]). They are also more likely to undergo postpartum hysterectomy (5.3 versus 0.04 percent in one study [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/8\" class=\"abstract_t\">8</a>]), <span class=\"nowrap\">uterine/iliac</span> artery ligation, or embolization of pelvic vessels. The risks of hemorrhage and postpartum hysterectomy are particularly high for women with previa-accreta. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta#H15006491\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;, section on 'Consequences'</a>.)</p><p>In women with severe hemorrhage, rapid, significant loss of intravascular volume can lead to hemodynamic instability, decreased oxygen delivery, decreased tissue perfusion, cellular hypoxia, organ damage, and death. In resource-rich countries, the maternal mortality rate associated with placenta previa is less than 1 percent [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/79\" class=\"abstract_t\">79</a>], but remains high in resource-poor countries where maternal anemia, lack of medical resources, and home births are more common [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/65\" class=\"abstract_t\">65</a>].</p><p>Severe maternal morbidity and maternal mortality can also be a consequence of amniotic fluid embolism syndrome. Several studies have observed a strong association between placental pathology, such as placenta previa, and amniotic fluid embolism syndrome [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/80-82\" class=\"abstract_t\">80-82</a>]. (See <a href=\"topic.htm?path=amniotic-fluid-embolism-syndrome\" class=\"medical medical_review\">&quot;Amniotic fluid embolism syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1830454\"><span class=\"h2\">Neonatal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The principal causes of neonatal morbidity and mortality are related to preterm delivery [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/83\" class=\"abstract_t\">83</a>]. In a systematic review and meta-analysis of placental implantation abnormalities and risk of preterm delivery, compared with no placenta previa, placenta previa was associated with a three- to fivefold increase in risk of [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/84\" class=\"abstract_t\">84</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preterm delivery &lt;37 weeks (44 percent, relative risk [RR] 5.32, 95% CI 4.39-6.45)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neonatal intensive care unit admission (RR 4.09, 95% CI 2.80-5.97)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neonatal death (RR 5.44, 95% CI 3.03-9.78)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Perinatal death (RR 3.01, 95% CI 1.41-6.43)</p><p/><p>In large studies, approximately 15 percent of patients with placenta previa delivered before 34 weeks of gestation [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/69,85\" class=\"abstract_t\">69,85</a>]. However, neonatal morbidity and mortality rates in pregnancies complicated by placenta previa have fallen over the past few decades because of improvements in obstetrical management (eg, antenatal corticosteroids), the liberal use of planned late preterm cesarean delivery, and improved neonatal care.</p><p>Neonatal anemia is also increased in pregnancies with placenta previa [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/86,87\" class=\"abstract_t\">86,87</a>].</p><p class=\"headingAnchor\" id=\"H1491902675\"><span class=\"h2\">Morbidity of low-lying placenta</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The morbidity of low-lying placenta (placental edge is &lt;2 cm from, but not over, the internal os) is less than that for placenta previa and decreases as the distance between the placental edge and internal cervical os increases. A study that compared pregnancy outcomes of 53 women with placental edge 1 to 10 mm versus 11 to 20 mm from the internal cervical os reported the following [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/88\" class=\"abstract_t\">88</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antepartum hemorrhage: 29 versus 3 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Postpartum hemorrhage: 21 versus 10 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preterm birth: 29 versus 3 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cesarean delivery: 75 versus 31 percent</p><p/><p class=\"headingAnchor\" id=\"H3509084378\"><span class=\"h1\">RECURRENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placenta previa recurs in 4 to 8 percent of subsequent pregnancies [<a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/16\" class=\"abstract_t\">16</a>]. </p><p class=\"headingAnchor\" id=\"H2532737269\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(See <a href=\"topic.htm?path=placenta-previa-management\" class=\"medical medical_review\">&quot;Placenta previa: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=placenta-previa-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Placenta previa (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>One to 6 percent of pregnant women display sonographic evidence of a placenta previa between 10 and 20 weeks of gestation when they undergo routine obstetrical ultrasound examination. The majority of these women are asymptomatic and 90 percent of these early cases resolve. (See <a href=\"#H1783334\" class=\"local\">'Asymptomatic finding on midtrimester ultrasound examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The characteristic symptom of placenta previa is painless vaginal bleeding, which occurs in up 90 percent of persistent cases. Ten to 20 percent of symptomatic women present with both uterine contractions and bleeding, similar to the presentation of abruptio placenta. In approximately one-third of pregnancies with persistent previa, the initial bleeding episode occurs prior to 30 weeks of gestation. (See <a href=\"#H524431\" class=\"local\">'Bleeding'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta previa should be suspected in any woman beyond 20 weeks of gestation who presents with vaginal bleeding. For women who have not had a second or third trimester ultrasound examination, antepartum bleeding should prompt sonographic determination of placental location <strong>before</strong> digital vaginal examination is performed because palpation of the placenta can cause severe hemorrhage. (See <a href=\"#H1398189\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of placenta previa is based on identification of placental tissue over the internal cervical os on an imaging study (<a href=\"image.htm?imageKey=OBGYN%2F74665\" class=\"graphic graphic_diagnosticimage graphicRef74665 \">image 1</a>). Transvaginal sonography should be performed to confirm a diagnosis made on transabdominal imaging. The distance (millimeters) that the placenta extends over the internal cervical os should be described in the diagnostic report. (See <a href=\"#H1398189\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous placenta previa, previous cesarean deliveries, and multiple gestation are major risk factors for placenta previa. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The likelihood of placenta previa at delivery is high when the previa persists into the third trimester and extends over the cervical os by &ge;25 mm. (See <a href=\"#H1783334\" class=\"local\">'Asymptomatic finding on midtrimester ultrasound examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some conditions that may be associated with placenta previa include placenta accreta, malpresentation, preterm labor or premature rupture of the membranes, vasa previa and velamentous insertion of the umbilical cord. (See <a href=\"#H1398279\" class=\"local\">'Placenta previa-accreta'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When placenta previa is diagnosed, the possibility of placenta <span class=\"nowrap\">previa-accreta/percreta</span> should be considered and excluded, especially in women with a previous cesarean delivery. (See <a href=\"#H1398279\" class=\"local\">'Placenta previa-accreta'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/1\" class=\"nounderline abstract_t\">Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 2003; 13:175.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/2\" class=\"nounderline abstract_t\">Cresswell JA, Ronsmans C, Calvert C, Filippi V. Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Trop Med Int Health 2013; 18:712.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/3\" class=\"nounderline abstract_t\">Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997; 177:1071.</a></li><li class=\"breakAll\">National Institutes of Health Consensus Development Conference Statement. NIH consensus development conference: Vaginal birth after cesarean: New insights. March 8&ndash;10, 2010.</li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/5\" class=\"nounderline abstract_t\">Ananth CV, Demissie K, Smulian JC, Vintzileos AM. Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions. Am J Obstet Gynecol 2003; 188:275.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/6\" class=\"nounderline abstract_t\">Demissie K, Breckenridge MB, Joseph L, Rhoads GG. Placenta previa: preponderance of male sex at birth. Am J Epidemiol 1999; 149:824.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/7\" class=\"nounderline abstract_t\">Yang Q, Wu Wen S, Caughey S, et al. Placenta previa: its relationship with race and the country of origin among Asian women. Acta Obstet Gynecol Scand 2008; 87:612.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/8\" class=\"nounderline abstract_t\">Rosenberg T, Pariente G, Sergienko R, et al. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet 2011; 284:47.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/9\" class=\"nounderline abstract_t\">Iyasu S, Saftlas AK, Rowley DL, et al. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol 1993; 168:1424.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/10\" class=\"nounderline abstract_t\">Macones GA, Sehdev HM, Parry S, et al. The association between maternal cocaine use and placenta previa. Am J Obstet Gynecol 1997; 177:1097.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/11\" class=\"nounderline abstract_t\">Rasmussen S, Albrechtsen S, Dalaker K. Obstetric history and the risk of placenta previa. Acta Obstet Gynecol Scand 2000; 79:502.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/12\" class=\"nounderline abstract_t\">Gurol-Urganci I, Cromwell DA, Edozien LC, et al. Risk of placenta previa in second birth after first birth cesarean section: a population-based study and meta-analysis. BMC Pregnancy Childbirth 2011; 11:95.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/13\" class=\"nounderline abstract_t\">Downes KL, Hinkle SN, Sjaarda LA, et al. Previous prelabor or intrapartum cesarean delivery and risk of placenta previa. Am J Obstet Gynecol 2015; 212:669.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/14\" class=\"nounderline abstract_t\">Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med 2017; :1.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/15\" class=\"nounderline abstract_t\">Shobeiri F, Jenabi E. Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 2017; 30:2985.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/16\" class=\"nounderline abstract_t\">Lavery JP. Placenta previa. Clin Obstet Gynecol 1990; 33:414.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/17\" class=\"nounderline abstract_t\">Klar M, Michels KB. Cesarean section and placental disorders in subsequent pregnancies--a meta-analysis. J Perinat Med 2014; 42:571.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/18\" class=\"nounderline abstract_t\">Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985; 66:89.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/19\" class=\"nounderline abstract_t\">Getahun D, Oyelese Y, Salihu HM, Ananth CV. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol 2006; 107:771.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/20\" class=\"nounderline abstract_t\">Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean deliveries and higher parity. Obstet Gynecol 2002; 99:976.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/21\" class=\"nounderline abstract_t\">Weis MA, Harper LM, Roehl KA, et al. Natural history of placenta previa in twins. Obstet Gynecol 2012; 120:753.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/22\" class=\"nounderline abstract_t\">Rose GL, Chapman MG. Aetiological factors in placenta praevia--a case controlled study. Br J Obstet Gynaecol 1986; 93:586.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/23\" class=\"nounderline abstract_t\">Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107:927.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/24\" class=\"nounderline abstract_t\">Dashe JS, McIntire DD, Ramus RM, et al. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol 2002; 99:692.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/25\" class=\"nounderline abstract_t\">Mouer JR. Placenta previa: antepartum conservative management, inpatient versus outpatient. Am J Obstet Gynecol 1994; 170:1683.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/26\" class=\"nounderline abstract_t\">Becker RH, Vonk R, Mende BC, et al. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001; 17:496.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/27\" class=\"nounderline abstract_t\">Taipale P, Hiilesmaa V, Yl&ouml;stalo P. Transvaginal ultrasonography at 18-23 weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol 1998; 12:422.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/28\" class=\"nounderline abstract_t\">Rosati P, Guariglia L. Clinical significance of placenta previa detected at early routine transvaginal scan. J Ultrasound Med 2000; 19:581.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/29\" class=\"nounderline abstract_t\">Oppenheimer L, Holmes P, Simpson N, Dabrowski A. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol 2001; 18:100.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/30\" class=\"nounderline abstract_t\">Cho JY, Lee YH, Moon MH, Lee JH. Difference in migration of placenta according to the location and type of placenta previa. J Clin Ultrasound 2008; 36:79.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/31\" class=\"nounderline abstract_t\">Fan D, Wu S, Liu L, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Sci Rep 2017; 7:40320.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/32\" class=\"nounderline abstract_t\">Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980; 137:687.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/33\" class=\"nounderline abstract_t\">Silver R, Depp R, Sabbagha RE, et al. Placenta previa: aggressive expectant management. Am J Obstet Gynecol 1984; 150:15.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/34\" class=\"nounderline abstract_t\">McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 1985; 65:176.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/35\" class=\"nounderline abstract_t\">Crane JM, van den Hof MC, Dodds L, et al. Neonatal outcomes with placenta previa. Obstet Gynecol 1999; 93:541.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/36\" class=\"nounderline abstract_t\">Ruiter L, Eschbach SJ, Burgers M, et al. Predictors for Emergency Cesarean Delivery in Women with Placenta Previa. Am J Perinatol 2016; 33:1407.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/37\" class=\"nounderline abstract_t\">Reddy UM, Abuhamad AZ, Levine D, et al. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop. Obstet Gynecol 2014; 123:1070.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/38\" class=\"nounderline abstract_t\">Thurmond A, Mendelson E, B&ouml;hm-V&eacute;lez M, et al. Role of imaging in second and third trimester bleeding. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215 Suppl:895.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/39\" class=\"nounderline abstract_t\">McClure N, Dornal JC. Early identification of placenta praevia. Br J Obstet Gynaecol 1990; 97:959.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/40\" class=\"nounderline abstract_t\">Oppenheimer L, Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can 2007; 29:261.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/41\" class=\"nounderline abstract_t\">Quant HS, Friedman AM, Wang E, et al. Transabdominal ultrasonography as a screening test for second-trimester placenta previa. Obstet Gynecol 2014; 123:628.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/42\" class=\"nounderline abstract_t\">Timor-Tritsch IE, Yunis RA. Confirming the safety of transvaginal sonography in patients suspected of placenta previa. Obstet Gynecol 1993; 81:742.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/43\" class=\"nounderline abstract_t\">Sunna E, Ziadeh S. Transvaginal and transabdominal ultrasound for the diagnosis of placenta praevia. J Obstet Gynaecol 1999; 19:152.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/44\" class=\"nounderline abstract_t\">Smith RS, Lauria MR, Comstock CH, et al. Transvaginal ultrasonography for all placentas that appear to be low-lying or over the internal cervical os. Ultrasound Obstet Gynecol 1997; 9:22.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/45\" class=\"nounderline abstract_t\">Sherman SJ, Carlson DE, Platt LD, Medearis AL. Transvaginal ultrasound: does it help in the diagnosis of placenta previa? Ultrasound Obstet Gynecol 1992; 2:256.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/46\" class=\"nounderline abstract_t\">Leerentveld RA, Gilberts EC, Arnold MJ, Wladimiroff JW. Accuracy and safety of transvaginal sonographic placental localization. Obstet Gynecol 1990; 76:759.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/47\" class=\"nounderline abstract_t\">Tuzovic L. Complete versus incomplete placenta previa and obstetric outcome. Int J Gynaecol Obstet 2006; 93:110.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/48\" class=\"nounderline abstract_t\">Oya A, Nakai A, Miyake H, et al. Risk factors for peripartum blood transfusion in women with placenta previa: a retrospective analysis. J Nippon Med Sch 2008; 75:146.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/49\" class=\"nounderline abstract_t\">Dola CP, Garite TJ, Dowling DD, et al. Placenta previa: does its type affect pregnancy outcome? Am J Perinatol 2003; 20:353.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/50\" class=\"nounderline abstract_t\">Bahar A, Abusham A, Eskandar M, et al. Risk factors and pregnancy outcome in different types of placenta previa. J Obstet Gynaecol Can 2009; 31:126.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/51\" class=\"nounderline abstract_t\">Ghourab S. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome? Ultrasound Obstet Gynecol 2001; 18:103.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/52\" class=\"nounderline abstract_t\">Zaitoun MM, El Behery MM, Abd El Hameed AA, Soliman BS. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? Arch Gynecol Obstet 2011; 284:867.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/53\" class=\"nounderline abstract_t\">Saitoh M, Ishihara K, Sekiya T, Araki T. Anticipation of uterine bleeding in placenta previa based on vaginal sonographic evaluation. Gynecol Obstet Invest 2002; 54:37.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/54\" class=\"nounderline abstract_t\">Ghi T, Contro E, Martina T, et al. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol 2009; 33:209.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/55\" class=\"nounderline abstract_t\">Stafford IA, Dashe JS, Shivvers SA, et al. Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. Obstet Gynecol 2010; 116:595.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/56\" class=\"nounderline abstract_t\">Sekiguchi A, Nakai A, Okuda N, et al. Consecutive cervical length measurements as a predictor of preterm cesarean section in complete placenta previa. J Clin Ultrasound 2015; 43:17.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/57\" class=\"nounderline abstract_t\">Shin JE, Shin JC, Lee Y, Kim SJ. Serial Change in Cervical Length for the Prediction of Emergency Cesarean Section in Placenta Previa. PLoS One 2016; 11:e0149036.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/58\" class=\"nounderline abstract_t\">Dawson WB, Dumas MD, Romano WM, et al. Translabial ultrasonography and placenta previa: does measurement of the os-placenta distance predict outcome? J Ultrasound Med 1996; 15:441.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/59\" class=\"nounderline abstract_t\">Simon EG, Fouche CJ, Perrotin F. Three-dimensional transvaginal sonography in third-trimester evaluation of placenta previa. Ultrasound Obstet Gynecol 2013; 41:465.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/60\" class=\"nounderline abstract_t\">Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006; 108:573.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/61\" class=\"nounderline abstract_t\">Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107:1226.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/62\" class=\"nounderline abstract_t\">Grobman WA, Gersnoviez R, Landon MB, et al. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007; 110:1249.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/63\" class=\"nounderline abstract_t\">Sheiner E, Shoham-Vardi I, Hallak M, et al. Placenta previa: obstetric risk factors and pregnancy outcome. J Matern Fetal Med 2001; 10:414.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/64\" class=\"nounderline abstract_t\">Gemer O, Segal S. Incidence and contribution of predisposing factors to transverse lie presentation. Int J Gynaecol Obstet 1994; 44:219.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/65\" class=\"nounderline abstract_t\">Olive EC, Roberts CL, Algert CS, Morris JM. Placenta praevia: maternal morbidity and place of birth. Aust N Z J Obstet Gynaecol 2005; 45:499.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/66\" class=\"nounderline abstract_t\">Brenner WE, Edelman DA, Hendricks CH. Characteristics of patients with placenta previa and results of &quot;expectant management&quot;. Am J Obstet Gynecol 1978; 132:180.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/67\" class=\"nounderline abstract_t\">Varma TR. Fetal growth and placental function in patients with placenta praevia. J Obstet Gynaecol Br Commonw 1973; 80:311.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/68\" class=\"nounderline abstract_t\">Newton ER, Barss V, Cetrulo CL. The epidemiology and clinical history of asymptomatic midtrimester placenta previa. Am J Obstet Gynecol 1984; 148:743.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/69\" class=\"nounderline abstract_t\">Ananth CV, Demissie K, Smulian JC, Vintzileos AM. Relationship among placenta previa, fetal growth restriction, and preterm delivery: a population-based study. Obstet Gynecol 2001; 98:299.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/70\" class=\"nounderline abstract_t\">R&auml;is&auml;nen S, Kancherla V, Kramer MR, et al. Placenta previa and the risk of delivering a small-for-gestational-age newborn. Obstet Gynecol 2014; 124:285.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/71\" class=\"nounderline abstract_t\">Weiner E, Miremberg H, Grinstein E, et al. The effect of placenta previa on fetal growth and pregnancy outcome, in correlation with placental pathology. J Perinatol 2016; 36:1073.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/72\" class=\"nounderline abstract_t\">Comeau J, Shaw L, Marcell CC, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983; 61:577.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/73\" class=\"nounderline abstract_t\">Harper LM, Odibo AO, Macones GA, et al. Effect of placenta previa on fetal growth. Am J Obstet Gynecol 2010; 203:330.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/74\" class=\"nounderline abstract_t\">N&oslash;rgaard LN, Pinborg A, Lidegaard &Oslash;, Bergholt T. A Danish national cohort study on neonatal outcome in singleton pregnancies with placenta previa. Acta Obstet Gynecol Scand 2012; 91:546.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/75\" class=\"nounderline abstract_t\">Kancherla V, R&auml;is&auml;nen S, Gissler M, et al. Placenta previa and risk of major congenital malformations among singleton births in Finland. Birth Defects Res A Clin Mol Teratol 2015; 103:527.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/76\" class=\"nounderline abstract_t\">Kancherla V, R&auml;is&auml;nen S, Gissler M, et al. Placenta previa and risk of major congenital malformations among singleton births in Finland. Birth Defects Res A Clin Mol Teratol 2015; 193:527.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/77\" class=\"nounderline abstract_t\">Crane JM, Van den Hof MC, Dodds L, et al. Maternal complications with placenta previa. Am J Perinatol 2000; 17:101.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/78\" class=\"nounderline abstract_t\">Fan D, Xia Q, Liu L, et al. The Incidence of Postpartum Hemorrhage in Pregnant Women with Placenta Previa: A Systematic Review and Meta-Analysis. PLoS One 2017; 12:e0170194.</a></li><li class=\"breakAll\">Clark, SL. Placenta previa and abruptio placentae. In: Creasy RK, Resnik R (Eds): Maternal Fetal Medicine: Principles and Practice. WB Saunders, Philadelphia 1999. p. 616.</li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/80\" class=\"nounderline abstract_t\">Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008; 199:49.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/81\" class=\"nounderline abstract_t\">Fong A, Chau CT, Pan D, Ogunyemi DA. Amniotic fluid embolism: antepartum, intrapartum and demographic factors. J Matern Fetal Neonatal Med 2015; 28:793.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/82\" class=\"nounderline abstract_t\">Spiliopoulos M, Puri I, Jain NJ, et al. Amniotic fluid embolism-risk factors, maternal and neonatal outcomes. J Matern Fetal Neonatal Med 2009; 22:439.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/83\" class=\"nounderline abstract_t\">Salihu HM, Li Q, Rouse DJ, Alexander GR. Placenta previa: neonatal death after live births in the United States. Am J Obstet Gynecol 2003; 188:1305.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/84\" class=\"nounderline abstract_t\">Vahanian SA, Lavery JA, Ananth CV, Vintzileos A. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol 2015; 213:S78.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/85\" class=\"nounderline abstract_t\">Zlatnik MG, Cheng YW, Norton ME, et al. Placenta previa and the risk of preterm delivery. J Matern Fetal Neonatal Med 2007; 20:719.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/86\" class=\"nounderline abstract_t\">Schneiderman M, Balayla J. A comparative study of neonatal outcomes in placenta previa versus cesarean for other indication at term. J Matern Fetal Neonatal Med 2013; 26:1121.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/87\" class=\"nounderline abstract_t\">Jang DG, Jo YS, Lee SJ, Lee GS. Risk factors of neonatal anemia in placenta previa. Int J Med Sci 2011; 8:554.</a></li><li><a href=\"https://www.uptodate.com/contents/placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality/abstract/88\" class=\"nounderline abstract_t\">Vergani P, Ornaghi S, Pozzi I, et al. Placenta previa: distance to internal os and mode of delivery. Am J Obstet Gynecol 2009; 201:266.e1.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6772 Version 28.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H14\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H1154183122\" id=\"outline-link-H1154183122\">Prevalence</a></li><li><a href=\"#H635460758\" id=\"outline-link-H635460758\">Risk factors</a></li></ul></li><li><a href=\"#H1783986\" id=\"outline-link-H1783986\">PATHOGENESIS</a></li><li><a href=\"#H1829329\" id=\"outline-link-H1829329\">PATHOPHYSIOLOGY OF BLEEDING</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL PRESENTATION AND COURSE</a><ul><li><a href=\"#H1783334\" id=\"outline-link-H1783334\">Asymptomatic finding on midtrimester ultrasound examination</a><ul><li><a href=\"#H1226729935\" id=\"outline-link-H1226729935\">- Natural history</a></li><li><a href=\"#H1398634279\" id=\"outline-link-H1398634279\">- Predicting presence at delivery</a></li></ul></li><li><a href=\"#H524431\" id=\"outline-link-H524431\">Bleeding</a></li></ul></li><li><a href=\"#H1398189\" id=\"outline-link-H1398189\">DIAGNOSIS</a><ul><li><a href=\"#H71784423\" id=\"outline-link-H71784423\">Diagnostic criteria</a></li><li><a href=\"#H1398236\" id=\"outline-link-H1398236\">Ultrasonography</a><ul><li><a href=\"#H1398243\" id=\"outline-link-H1398243\">- Transabdominal</a><ul><li><a href=\"#H4069193567\" id=\"outline-link-H4069193567\">Screening performance</a></li><li><a href=\"#H4241803197\" id=\"outline-link-H4241803197\">Technique and pitfalls</a></li></ul></li><li><a href=\"#H1398250\" id=\"outline-link-H1398250\">- Transvaginal</a><ul><li><a href=\"#H651487460\" id=\"outline-link-H651487460\">Performance</a></li><li><a href=\"#H2068534580\" id=\"outline-link-H2068534580\">Characteristics predictive of bleeding</a></li></ul></li><li><a href=\"#H2798478593\" id=\"outline-link-H2798478593\">- Other ultrasound techniques</a></li></ul></li><li><a href=\"#H1398257\" id=\"outline-link-H1398257\">Magnetic resonance imaging</a></li></ul></li><li><a href=\"#H1398271\" id=\"outline-link-H1398271\">ASSOCIATED FINDINGS</a><ul><li><a href=\"#H1398279\" id=\"outline-link-H1398279\">Placenta previa-accreta</a></li><li><a href=\"#H1235055223\" id=\"outline-link-H1235055223\">Other associated findings</a></li></ul></li><li><a href=\"#H1830439\" id=\"outline-link-H1830439\">MORBIDITY AND MORTALITY</a><ul><li><a href=\"#H1830447\" id=\"outline-link-H1830447\">Maternal</a></li><li><a href=\"#H1830454\" id=\"outline-link-H1830454\">Neonatal</a></li><li><a href=\"#H1491902675\" id=\"outline-link-H1491902675\">Morbidity of low-lying placenta</a></li></ul></li><li><a href=\"#H3509084378\" id=\"outline-link-H3509084378\">RECURRENCE</a></li><li><a href=\"#H2532737269\" id=\"outline-link-H2532737269\">MANAGEMENT</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H31430300\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"OBGYN/6772|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/74665\" class=\"graphic graphic_diagnosticimage\">- Complete placenta previa</a></li><li><a href=\"image.htm?imageKey=OBGYN/55703\" class=\"graphic graphic_diagnosticimage\">- Low lying placenta</a></li><li><a href=\"image.htm?imageKey=OBGYN/76545\" class=\"graphic graphic_diagnosticimage\">- Overdistended bladder mimicking placenta previa</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=amniotic-fluid-embolism-syndrome\" class=\"medical medical_review\">Amniotic fluid embolism syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fetal-growth-restriction-evaluation-and-management\" class=\"medical medical_review\">Fetal growth restriction: Evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-spontaneous-preterm-birth\" class=\"medical medical_review\">Pathogenesis of spontaneous preterm birth</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placenta-previa-the-basics\" class=\"medical medical_basics\">Patient education: Placenta previa (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placenta-previa-management\" class=\"medical medical_review\">Placenta previa: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis\" class=\"medical medical_review\">Placental abruption: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preterm-prelabor-rupture-of-membranes\" class=\"medical medical_review\">Preterm prelabor rupture of membranes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">Velamentous umbilical cord insertion and vasa previa</a></li></ul></div></div>","javascript":null}